Drug Type Small molecule drug |
Synonyms SB P8B2, SBP8B2 |
Target |
Mechanism FtsZ inhibitors(bacterial FtsZ inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H32N4O2 |
InChIKeyMMGPENLTZQKVBO-UHFFFAOYSA-N |
CAS Registry1259926-60-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tuberculosis | Preclinical | US | 02 Dec 2010 |